Nos publications
Mise à jour août 2024
| Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Commentary on "Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections" | Drews SJ | 2024 | J Thromb Haemost | View Commentary on "Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections" | Researchers | Epidemiology research |
| Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system | Kou Y, Kumaran D, Howell A, Ramirez-Arcos S | 2024 | Transfusion | View Comparable bacterial growth in platelet concentrates suspended in plasma and platelet additive solution and improved detection of bacterial contamination using a new generation automated culture system | Researchers | Basic research |
| Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicine | Isiksacan Z, D’Alessandro A, McKenna DH, Tessier SN, Kucukal E, Gokaltun AA, William N, Sandlin RD, Bischof J, Mohandas N, Busch MP, Elbuken C, Gurkan UA, Toner M, Acker JP, Yarmush ML, Usta OB | 2024 | PNAS | View Reply to Kaestner et al.: Pioneering quantitative platforms for stored red blood cell assessment open the door for precision transfusion medicine | Researchers | Benchmarking and standard setting |
| Alberta’s research priorities to advance organ donation and transplantation: an ecosystem-based and consensus-driven approach to strategic research planning | Davoodi S, Gongal P, Delaney S, Acker J, Boulet D, Boulet T, Dijke E, Elliot J, Halloran K, Halpin A, Hartell D, Kemp L, Kramer A, Lam N, Mager D, Mokoena T, Pepper A, Powell L, Tandon P, Wilson M, Wilkins R, Woolfsmith J, West L | 2024 | Can Heal Pol | View Alberta’s research priorities to advance organ donation and transplantation: an ecosystem-based and consensus-driven approach to strategic research planning | Researchers | Benchmarking and standard setting |
| Thrombotic triad in microgravity | Elahi MM, Witt AN, Pryzdial ELG, McBeth PB | 2024 | Thromb Res | View Thrombotic triad in microgravity | Researchers | Basic research |
| Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 | Drews SJ, Charlton C, O'Brien SF, Burugu S, Denomme GA | 2024 | Vox Sang | View Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020 | Researchers | Epidemiology research |
| Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective | Hasan T, Pasala AR, Hassan D, Hanotaux J, Allan DS, Maganti HB | 2024 | Curr Oncol | View Homing and Engraftment of Hematopoietic Stem Cells Following Transplantation: A Pre-Clinical Perspective | Researchers | Clinical research |
| Améliorer la sécurité des transfusions de plaquettes grâce à la réduction des agents pathogènes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité des transfusions de plaquettes grâce à la réduction des agents pathogènes | General public | Other |
| Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blake JT, Ganz K, Seftel M, Allan D | 2024 | Vox Sang | View Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulation | Blood operators | Benchmarking and standard setting |
| The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A | Ay C, Kovacevic KD, Kraemmer D, Schoergenhofer C, Gelbenegger G, Firbas C, Quehenberger P, Jilma-Stohlawetz P, Gilbert JC, Zhu S, Beliveau M, Koenig F, Iorio A, Jilma B, Derhaschnig U, Pabinger I | 2023 | Blood | View The von Willebrand factor-binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A | Health care providers | Clinical research |
| Data for assessing red blood cell deformability from microscopy images using deep learning | Lamoureux ES, Islamzada E, Wiens MVJ, Matthews K, Duffy SP, Ma H | 2023 | Data Brief | View Data for assessing red blood cell deformability from microscopy images using deep learning | Researchers | New or improved product or process |
| Summary of adverse transfusion reactions 2018-2023 | Yan M | 2023 | Blood.ca website | View Summary of adverse transfusion reactions 2018-2023 | Blood operators | Benchmarking and standard setting |
| Hämolytische Erkrankung des Neugeborenen (Morbus haemolyticus neonatorum; MHN): ABO-Unverträglichkeit | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View Hämolytische Erkrankung des Neugeborenen (Morbus haemolyticus neonatorum; MHN): ABO-Unverträglichkeit | General public | Other |
| Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine | Isiksacan Z, D’Alessandro A, Wolf SM, McKenna DH, Tessier SN, Kucukal E, Gokaltun AA, William N, Sandlin RD, Bischof J, Mohandas N, Busch MP, Elbuken C, Gurkan UA, Toner M, Acker JP, Yarmush ML, Usta OB | 2023 | Proceedings of the National Academy of Sciences | View Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine | Researchers | Basic research |
| Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada | Haw J, Walrond J, Jayachandran J, Dordunoo D, Eche-Ameh H, Muwhen U, Phiri P, Rastogi J, Tinga B | 2023 | Transfusion | View Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada | Researchers | Ethical, legal & social implications research |
| Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups | Blake JT, Parmar G, Ganz K, Seftel MD, Allan DS | 2023 | Transfusion | View Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups | Health care providers | New or improved product or process |
| Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses | Kassardjian A, Sun E, Sookhoo J, Muthuraman K, Boligan KF, Kucharska I, Rujas E, Jetha A, Branch DR, Babiuk S, Barber B, Julien JP | 2023 | Cell Rep | View Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses | Researchers | Basic research |
| Towards the crux of sex-dependent variability in red cell concentrates | William N, Osmani R, Acker JP | 2023 | Transfus Apher Sci | View Towards the crux of sex-dependent variability in red cell concentrates | Researchers | Basic research |
| The impact of biological age of red blood cell on in vitro endothelial activation markers | Alshalani A, Beuger BM, Tuip-de Boer AM, van Bruggen R, Acker JP, Juffermans NP | 2023 | Front Physiol | View The impact of biological age of red blood cell on in vitro endothelial activation markers | Researchers | Basic research |
| The importance of iron for whole blood donors: a Canadian perspective | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Benchmarking and standard setting |
| Chapitre 14. Aphérèse thérapeutique | Oliver M, Patriquin C | 2023 | Guide de la pratique transfusionnelle | View Chapitre 14. Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
| Extracellular vesicles: effectors of transfusion-related acute lung injury | Kuebler WM, William N, Post M, Acker JP, McVey MJ | 2023 | Am J Physiol Lung Cell | View Extracellular vesicles: effectors of transfusion-related acute lung injury | Researchers | Clinical research |
| Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease | Hajjaj OI, Cserti-Gazdewich C, Dumevska L, Hanna M, Lau W, Lieberman L | 2023 | Transfusion | View Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease | Health care providers | Clinical research |
| How do I provide rare red cells to patients? | Laureano M, Clarke G, Yan MTS | 2023 | Transfusion | View How do I provide rare red cells to patients? | Health care providers | Benchmarking and standard setting |
| Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder | Venier LM, Clerici B, Bissola AL, Modi D, Jevtic SD, Radford M, Mahamad S, Nazy I, Arnold DM | 2023 | Int J Hematol | View Unique features of vaccine-induced immune thrombotic thrombocytopenia; a new anti-platelet factor 4 antibody-mediated disorder | Researchers | Clinical research |
| Surveillance Report 2022 | O'Brien S | 2023 | Blood.ca website | View Surveillance Report 2022 | Blood operators | Benchmarking and standard setting |
| La maladie hémolytique du nouveau-né (immunisation antirhésus et anticorps non ABO) | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View La maladie hémolytique du nouveau-né (immunisation antirhésus et anticorps non ABO) | General public | Other |
| Barriers and enablers to and strategies for pro-moting plasma donation: overarching protocol for three systematic reviews | Etherington C, Palumbo A, Holloway K, Meyer S, Labrecque M, Rubini K, Shorr R, Welch V, Gibson E, Foster T, Haw J, Vesnaver E, Maharshi MT, O'Brien S, MacPherson P, Dogba J, Steed T, Goldman M, Presseau J | 2023 | PsyArXiv | View Barriers and enablers to and strategies for pro-moting plasma donation: overarching protocol for three systematic reviews | Researchers | MSM research |
| Significant rosettes observed in monocyte monolayer assay due to complement-binding antibodies | Sandhu G, Lipman T, Bodnar M, Bienz MN, Branch DR | 2023 | Transfusion | View Significant rosettes observed in monocyte monolayer assay due to complement-binding antibodies | Researchers | Basic research |
| Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients | Abrahamyan L, Tomlinson G, Callum J, Carcone S, Grewal D, Bartoszko J, Krahn M, Karkouti K | 2023 | JAMA Surg | View Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients | Health care providers | Clinical research |
| Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice | Eltringham-Smith LJ, Meixner SC, Pryzdial ELG, Sheffield WP | 2023 | Sci Rep | View Correction of haemorrhagic shock-associated coagulopathy and impaired haemostasis by plasma, prothrombin complex concentrates or an activated protein C-targeted DNA aptamer in mice | Researchers | Basic research |
| Supplemental information Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses | Kassardjian A, Sun E, Sookhoo J, Muthuraman K, Boligan KF, Kucharska I, Rujas E, Jetha A, Branch DR, Babiuk S, Barber B, Julien J-P | 2023 | Cell Rep | View Supplemental information Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses | Researchers | Basic research |
| Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada | Holloway K | 2023 | Transfus Med | View Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada | Blood operators | Ethical, legal & social implications research |
| Evolving the gay, bisexual and other men who have sex with men time-based deferral to sexual risk screening for all donors: The contribution of Canadian research programmes | Caffrey N, O'Brien SF, Walsh GM, Haw J, Goldman M | 2023 | Vox Sang | View Evolving the gay, bisexual and other men who have sex with men time-based deferral to sexual risk screening for all donors: The contribution of Canadian research programmes | Researchers | MSM epidemiology research |
| Cultured CD71+ erythroid cells modulate the host immune response | Alshalani A, Beuger BM, van Bruggen R, Acker JP, Juffermans NP | 2023 | Transfus Med | View Cultured CD71+ erythroid cells modulate the host immune response | Researchers | Basic research |
| Importance du fer chez les donneurs de sang total : la perspective canadienne | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Benchmarking and standard setting |
| The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety | Parmar G, Allan DS, Morris G, Dibdin N, Ganz K, Mostert K, Paulson K, Petraszko T, Stevens N, Seftel MD | 2023 | Curr Oncol | View The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety | Health care providers | Clinical research |
| Engineered Compounds to Control Ice Nucleation and Recrystallization | William N, Mangan S, Ben RN, Acker JP | 2023 | Ann Rev Biomed Eng | View Engineered Compounds to Control Ice Nucleation and Recrystallization | Researchers | New or improved product or process |
| The under-appreciated world of the serpin family of serine proteinase inhibitors | Bouton M-C, Geiger M, Sheffield WP, Irving JA, Lomas DA, Song S, Satyanarayanan RS, Zhang L, McFadden G, Lucas AR | 2023 | EMBO Mol Med | View The under-appreciated world of the serpin family of serine proteinase inhibitors | Researchers | Basic research |
| Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2023 | Microbiol Spectr | View Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 | Researchers | Clinical research |
| Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors | Pozzo di Borgo A, Germain M, O'Brien SF, Delage G, Renaud C, Lewin A | 2023 | Vox Sang | View Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors | Researchers | Clinical research |
| Do Children With an Allergic Transfusion Reaction Require Premedication or All Blood Products? | Bahabri A, Barty R, Li N, Liu Y, Kovalova T, Chan AKC | 2023 | J Pediatr Hematol Oncol | View Do Children With an Allergic Transfusion Reaction Require Premedication or All Blood Products? | Health care providers | Clinical research |
| How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation | Haw J, Holloway K, Goldman M | 2023 | Transfus Clin Biol | View How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation | Researchers | Ethical, legal & social implications research |
| Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model | Wabnitz H, Cruz-Leal Y, Lazarus AH | 2023 | Transfusion | View Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model | Researchers | Basic research |
| La maladie hémolytique du nouveau-né (incompatibilité ABO) | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View La maladie hémolytique du nouveau-né (incompatibilité ABO) | General public | Other |
| Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression | Li J, Karakas D, Xue F, Chen Y, Zhu G, Yucel YH, MacParland SA, Zhang H, Semple JW, Freedman J, Shi Q, Ni H | 2023 | Research | View Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression | Researchers | Basic research |
| Transfusion Camp Rwanda: A prospective feasibility study evaluating the delivery of Transfusion Camp to a multidisciplinary group of postgraduate medical trainees in Rwanda | Hagumimana J, Skelton T, Pendergrast J, Nizeyimana F, Masaisa F, Kanyamuhunga A, Gashaija C, Chargé S, Kapitany C, Morgan M, Meirovich H, Lin Y | 2023 | Transfusion | View Transfusion Camp Rwanda: A prospective feasibility study evaluating the delivery of Transfusion Camp to a multidisciplinary group of postgraduate medical trainees in Rwanda | Health care providers | Education research |
| Taking lessons from nature to improve cell therapy cryopreservation | Acker J, William N, Coatham M | 2023 | Cell Gene Ther Insights | View Taking lessons from nature to improve cell therapy cryopreservation | Researchers | Basic research |
| Molecular Screening of Blood Donors for Babesia in Tyrol, Austria | Bloch EM, Siller A, Tonnetti L, Drews SJ, Spencer BR, Hedges D, Mergenthal T, Weber-Schehl M, Astl M, Patel EU, Gaber M, Schennach H | 2023 | Transfus Med Hemother | View Molecular Screening of Blood Donors for Babesia in Tyrol, Austria | Researchers | Clinical research |
| Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE, Kelton JG, Nazy I | 2023 | Blood Adv | View Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Researchers | Clinical research |